Mitochondrial changes associated with demyelination: Consequences for axonal integrity

Mitochondrion

Volumn 12, Issue 2, 2012, Pages 173-179

  Campbell, Graham R ^a   Mahad, Don J ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Axonal degeneration; Demyelination; Mitochondria; Multiple sclerosis

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CELL NUCLEUS DNA; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.6; UBIQUINOL CYTOCHROME C REDUCTASE;

CELL FUNCTION; CELL LOSS; CELL METABOLISM; CELL PROTECTION; DEMYELINATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; ENERGY METABOLISM; HUMAN; MITOCHONDRION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

AXONS; DEMYELINATING DISEASES; HUMANS; MITOCHONDRIA; MULTIPLE SCLEROSIS;

EID: 84858009274     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.03.007     Document Type: Review

References (78)

1. Amiri M., Hollenbeck P.J. Mitochondrial biogenesis in the axons of vertebrate peripheral neurons. Dev. Neurobiol. 2008, 68(11):1348-1361.
2. Andrews H., White K., et al. Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse. J. Neurosci. Res. 2006, 83(8):1533-1539.
3. Anthony D.C., Miller K.M., et al. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol. 1998, 87(1-2):62-72.
4. Balaratnasingam C., Morgan W.H., et al. Heterogeneous distribution of axonal cytoskeleton proteins in the human optic nerve. Invest Ophthalmol Vis Sci 2009, 50(6):2824-2838.
5. Barron M.J., Griffiths P., et al. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br. J. Ophthalmol. 2004, 88(2):286-290.
6. Bechtold D.A., Kapoor R., et al. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann. Neurol. 2004, 55(5):607-616.
7. Bechtold D.A., Miller S.J., et al. Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J. Neurol. 2006, 253(12):1542-1551.
8. Bedlack R.S., Vu T., et al. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2004, 29(3):364-368.
9. Bjartmar C., Wujek J.R., et al. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 2003, 206(2):165-171.
10. Black J.A., Renganathan M., et al. Sodium channel Na(v)1.6 is expressed along nonmyelinated axons and it contributes to conduction. Brain Res. Mol. Brain Res. 2002, 105(1-2):19-28.
11. Black J.A., Liu S., et al. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine. Ann. Neurol. 2007, 62(1):21-33.
12. Black J.A., Newcombe J., et al. Sodium channel expression within chronic multiple sclerosis plaques. J. Neuropathol. Exp. Neurol. 2007, 66(9):828-837.
13. Bristow E.A., Griffiths P.G., et al. The distribution of mitochondrial activity in relation to optic nerve structure. Arch. Ophthalmol. 2002, 120(6):791-796.
14. Brown G.C., Cooper C.E. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994, 356(2-3):295-298.
15. Carelli V., Ross-Cisneros F.N., et al. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem. Int. 2002, 40(6):573-584.
16. Carroll W.M., Jennings A.R., et al. Galactocerebroside antiserum causes demyelination of cat optic nerve. Brain Res. 1985, 330(2):378-381.
17. Clementi E., Brown G.C., et al. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl Acad. Sci. U.S.A. 1998, 95(13):7631-7636.
18. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 2005, 6(11):889-898.
19. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372(9648):1502-1517.
20. Craner M.J., Hains B.C., et al. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 2004, 127(Pt 2):294-303.
21. Craner M.J., Damarjian T.G., et al. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 2005, 49(2):220-229.
22. Davis A.F., Clayton D.A. In situ localization of mitochondrial DNA replication in intact mammalian cells. J. Cell Biol. 1996, 135(4):883-893.
23. De Vos K.J., Chapman A.L., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 2007, 16(22):2720-2728.
24. de Waegh S.M., Lee V.M., et al. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992, 68(3):451-463.
25. DeLuca G.C., Ebers G.C., et al. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 2004, 127(Pt 5):1009-1018.
26. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 2003, 348(26):2656-2668.
27. Dutta R., McDonough J., et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann. Neurol. 2006, 59(3):478-489.
28. Edgar J.M., McCulloch M.C., et al. Distribution of mitochondria along small-diameter myelinated central nervous system axons. J. Neurosci. Res. 2008, 86(10):2250-2257.
29. Erol I., Alehan F., et al. Demyelinating disease of central and peripheral nervous systems associated with a A8344G mutation in tRNALys. Neuromuscul. Disord. 2009, 19(4):275-278.
30. Ferguson B., Matyszak M.K., et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120(Pt 3):393-399.
31. Gentleman S.M., Nash M.J., et al. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett. 1993, 160(2):139-144.
32. Gioio A.E., Eyman M., et al. Local synthesis of nuclear-encoded mitochondrial proteins in the presynaptic nerve terminal. J. Neurosci. Res. 2001, 64(5):447-453.
33. Harding A.E., Sweeney M.G., et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992, 115(Pt 4):979-989.
34. Hogan V., White K., et al. Increase in mitochondrial density within axons and supporting cells in response to demyelination in the Plp1 mouse model. J. Neurosci. Res. 2009, 87(2):452-459.
35. Hohlfeld R. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 1997, 120(Pt 5):865-916.
36. Kaplan M.R., Cho M.H., et al. Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier. Neuron 2001, 30(1):105-119.
37. Kapoor R., Davies M., et al. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann. Neurol. 2003, 53(2):174-180.
38. Kapoor R., Furby J., et al. Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol. 2010, 9(7):681-688.
39. Kiryu-Seo S., Ohno N., et al. Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J. Neurosci. 2010, 30(19):6658-6666.
40. Kornek B., Storch M.K., et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001, 124(Pt 6):1114-1124.
41. Kovacs G.G., Hoftberger R., et al. Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain 2005, 128(Pt 1):35-41.
42. Kutzelnigg A., Lucchinetti C.F., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128(Pt 11):2705-2712.
43. Lassmann H. Axonal injury in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2003, 74(6):695-697.
44. Lo A.C., Saab C.Y., et al. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J. Neurophysiol. 2003, 90(5):3566-3571.
45. Lu F., Selak M., et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 2000, 177(2):95-103.
46. Mahad D.J., Ziabreva I., et al. Mitochondrial changes within axons in multiple sclerosis. Brain 2009, 132(Pt 5):1161-1174.
47. Miller K.E., Sheetz M.P. Axonal mitochondrial transport and potential are correlated. J. Cell Sci. 2004, 117(Pt 13):2791-2804.
48. Mizukami K., Sasaki M., et al. Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study. Acta Neuropathol. 1992, 83(4):449-452.
49. Morris R.L., Hollenbeck P.J. The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J. Cell Sci. 1993, 104(Pt 3):917-927.
50. Mutsaers S.E., Carroll W.M. Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve. Acta Neuropathol. 1998, 96(2):139-143.
51. Neumann H., Medana I.M., et al. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 2002, 25(6):313-319.
52. Nicot A., Ratnakar P.V., et al. Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain 2003, 126(Pt 2):398-412.
53. Nishino I., Spinazzola A., et al. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999, 283(5402):689-692.
54. Povlishock J.T. Traumatically induced axonal injury: pathogenesis and pathobiological implications. Brain Pathol. 1992, 2(1):1-12.
55. Qi X., Lewin A.S., et al. Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J. Biol. Chem. 2006, 281(42):31950-31962.
56. Qi X., Lewin A.S., et al. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci 2007, 48(2):681-691.
57. Sathornsumetee S., McGavern D.B., et al. Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis. Am. J. Pathol. 2000, 157(4):1365-1376.
58. Shrager P. Sodium channels in single demyelinated mammalian axons. Brain Res. 1989, 483(1):149-154.
59. Smith K.J., Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2002, 1(4):232-241.
60. Sparaco M., Bonilla E., et al. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J. Neuropathol. Exp. Neurol. 1993, 52(1):1-10.
61. Stys P.K., Waxman S.G., et al. Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter. Ann. Neurol. 1991, 30(3):375-380.
62. Stys P.K., Waxman S.G., et al. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+channels and Na(+)-Ca2+ exchanger. J. Neurosci. 1992, 12(2):430-439.
63. Szigeti K., Sule N., et al. Increased blood-brain barrier permeability with thymidine phosphorylase deficiency. Ann. Neurol. 2004, 56(6):881-886.
64. Taylor R.W., Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6(5):389-402.
65. Taylor R.W., Schaefer A.M., et al. The diagnosis of mitochondrial muscle disease. Neuromuscul. Disord. 2004, 14(4):237-245.
66. Tran M., Bhargava R., et al. Leber hereditary optic neuropathy, progressive visual loss, and multiple-sclerosis-like symptoms. Am. J. Ophthalmol. 2001, 132(4):591-593.
67. Trapp B.D., Stys P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009, 8(3):280-291.
68. Trapp B.D., Peterson J., et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338(5):278-285.
69. Waxman S.G. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat. Rev. Neurosci. 2006, 7(12):932-941.
70. Waxman S.G. Axonal dysfunction in chronic multiple sclerosis: meltdown in the membrane. Ann. Neurol. 2008, 63(4):411-413.
71. Waxman S.G. Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status. Nat. Clin. Pract. Neurol. 2008, 4(3):159-169.
72. Waxman S.G., Black J.A., et al. Low density of sodium channels supports action potential conduction in axons of neonatal rat optic nerve. Proc. Natl Acad. Sci. U.S.A. 1989, 86(4):1406-1410.
73. Waxman S.G., Black J.A., et al. Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve. Brain Res. 1992, 574:105-119.
74. Werner S.R., Saha J.K., et al. Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration. J. Mol. Neurosci. 2010, 42(2):210-225.
75. Witte M.E., Bo L., et al. Enhanced number and activity of mitochondria in multiple sclerosis lesions. J. Pathol. 2009, 219(2):193-204.
76. Yin X., Baek R.C., et al. Evolution of a neuroprotective function of central nervous system myelin. J. Cell Biol. 2006, 172(3):469-478.
77. Young E.A., Fowler C.D., et al. Imaging correlates of decreased axonal Na+/K+ATPase in chronic multiple sclerosis lesions. Ann. Neurol. 2008, 63(4):428-435.
78. Zeis T., Kinter J., et al. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes. J. Neuroimmunol. 2008, 205(1-2):10-19.